VipStockReports

Intraday Movers - ISIS Pharmaceuticals, Inc.(NASDAQ:ISIS), ACADIA Pharmaceuticals Inc.(NASDAQ:ACAD), Lululemon Athletica inc.(NASDAQ:LULU), Symantec Corporation(NASDAQ:SYMC)

 
Repost This

Middletown, DE -- (SBWIRE) -- 09/10/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: ISIS Pharmaceuticals, Inc.(NASDAQ:ISIS), ACADIA Pharmaceuticals Inc.(NASDAQ:ACAD), Lululemon Athletica inc.(NASDAQ:LULU), Symantec Corporation(NASDAQ:SYMC)

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) opened the session at $30.31, remained amid the day range of $29.85 - $31.88, and closed the session at $31.81. The stock showed a positive performance of +13.93% in previous trading session. The stock gained a volume of 4.55 million shares and the average volume of the stock remained 1.20 million shares. Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company?s flagship product, KYNAMRO injection, is an apo-B synthesis inhibitor for patients with homozygous familial hypercholesterolemia for the reduction of low-density lipoprotein cholesterol.

Why Should Investors Buy ISIS After The Recent Gain? Just Go Here and Find Out

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) traded with volume of 4.32 million shares in the prior session and the average volume of the stock remained 1.68 million shares. The 52 week range of the stock remained $1.73 - $23.49. The stock showed a positive movement of +6.45% and closed its session at $22.79. The market capitalization of the stock remained 2.02 billion. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The company has a pipeline of product candidates led by pimavanserin, which is in Phase III development stage for the treatment of Parkinson's disease psychosis.

Will ACAD Continue To Move Higher? Find Out Here

Lululemon Athletica inc.(NASDAQ:LULU) exchanged 4.02 million shares and the average volume remained 1.88 million shares. The stock escalated +2.58% and closed the session at $71.28. The beta of the stock remained 2.16 and the EPS of the stock remained 1.86. The shares outstanding of the stock remained 112.52 million. lululemon athletica inc., together with its subsidiaries, designs, manufactures, and distributes athletic apparel and accessories for women, men, and female youth. It operates in three segments: Corporate-Owned Stores, Direct To Consumer, and Other. The company?s line of apparel include fitness pants, shorts, tops, and jackets for healthy lifestyle activities, such as yoga, running, and general fitness.

For How Long LULU will fight for Profitability? Read This Trend Analysis report

Symantec Corporation (NASDAQ:SYMC) opened the session at $25.50, remained amid the day range of $25.38 - $25.63, and closed the session at $25.39. The stock showed a positive performance of +0.15% in previous trading session. The stock gained a volume of 4.03 million shares and the average volume of the stock remained 5.49 million shares. Symantec Corporation and its subsidiaries provide security, backup, and availability solutions worldwide. Its products and services protect people and information in any digital environment from mobile devices, enterprise data centers, and cloud-based systems. The company operates in Consumer, Security and Compliance, Storage and Server Management, and Services segments.

For How Long SYMC’s Gloss will Attract Investors? Find out via this report

About VipStockReports.com:
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!

Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.

Disclaimer:
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.

VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.

Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/